Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-1934
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis ; volume:36 ; number:3 ; day:1 ; month:3 ; year:2022 ; pages:283-300 ; date:3.2022
CNS drugs ; 36, Heft 3 (1.3.2022), 283-300, 3.2022

Klassifikation
Medizin, Gesundheit

Urheber
Yu, Huixin
Graham, Gordon
David, Olivier J.
Kahn, Joseph M.
Savelieva, Marina
Pigeolet, Etienne
Gupta, Ayan Das
Pingili, Ratnakar
Willi, Roman
Ramanathan, Krishnan
Kieseier, Bernd C.
Häring, Dieter A.
Bagger, Morten
Soelberg Sørensen, Per
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s40263-021-00895-w
URN
urn:nbn:de:101:1-2022060819572261132130
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:37 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Yu, Huixin
  • Graham, Gordon
  • David, Olivier J.
  • Kahn, Joseph M.
  • Savelieva, Marina
  • Pigeolet, Etienne
  • Gupta, Ayan Das
  • Pingili, Ratnakar
  • Willi, Roman
  • Ramanathan, Krishnan
  • Kieseier, Bernd C.
  • Häring, Dieter A.
  • Bagger, Morten
  • Soelberg Sørensen, Per
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis

Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple Sclerosis

Postural Control in Relapsing-Remitting Multiple Sclerosis

Postural Control in Relapsing-Remitting Multiple Sclerosis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis

Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Serum prolactin in patients with relapsing remitting multiple sclerosis

Serum prolactin in patients with relapsing remitting multiple sclerosis

Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis

Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis

Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis

Verbundene Objekte